Clinical Trial Update: Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging [NA]

View source ↗

Summary

A clinical trial update notes ongoing recruitment for a study evaluating whether 5 mg of melatonin can modify cognition and brain health in aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Decline
• Cognitive Impairment

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Natalie Denburg | Conditions: Mild Cognitive Impairment, Cognitive Decline | NA | Status: RECRUITING